Why invest?
We enter 2026 with a strengthened balance sheet, a scalable organisation, and a product portfolio with technological innovations that are already making a significant difference for our customers. We also anticipate a substantial increase in procurement activity in the coming year, and we are ready to meet this demand. Our platform, MobiMed, enables our customers to address operational needs with digital solutions that both increase healthcare capacity and improve patient safety.
Trusted by
Press releases
Ortivus AB today announces that it has completed the sale of its entire shareholding in the technology company H&E Solutions AB (Evam) for a purchase price of SEK 5.2 million. The transaction results in a realised profit and strengthens Ortivus’ liquidity...
Ortivus is pleased to announce the appointment of Matti Zemack as the new Chief Product Officer (CPO). In this strategic role, Zemack will lead the company's product vision and development, driving the next generation of Ortivus's innovative eHealth and...